Moffitt Cancer Center researchers identify hidden target of ROS1 inhibitor lorlatinib

  • Post author:
  • Post category:uncategorized

Targeted cancer drugs are widely used because of their ability to inhibit specific proteins involved in cancer development with fewer side effects compared to chemotherapy drugs.